Oncology and biomedicine terminology · MLC-0111
Oncology and biomedicine terms: N (519)
- nuzefatide pevedotinA bicyclic peptide targeting Ephrin receptor A2 (EphA2) and conjugated, through an inert sarcosine spacer...
- NY-ESO-1 peptide vaccineA cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1), an...
- NY-ESO-1 peptides/threitolceramide-6-loaded nanoparticles PORT-3An immunomodulating agent and nanovaccine composed of the invariant natural killer T-cell (iNKT) agonist...
- NY-ESO-1 plasmid DNA cancer vaccineA plasmid DNA encoding an immunogenic peptide derived from the cancer-testis antigen NY-ESO-1 with potential...
- NY-ESO-1 protein vaccine plus Montanide ISA-51 VGA cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1) and...
- NY-ESO-1 protein/microparticle MDP/bacterial DNA-containing MIS416 vaccineA combination preparation composed of a protein derived from the human tumor-associated antigen (TAA)...
- NY-ESO-1 reactive TCR retroviral vector transduced autologous PBLHuman autologous peripheral blood lymphocytes (PBLs) transduced with a retroviral vector encoding a T cell...
- NY-ESO-1(157-165) peptide-pulsed autologous dendritic cell vaccineA cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with a peptide derived from...
- NY-ESO-1b peptide vaccineA recombinant nonapeptide used as an antineoplastic vaccine. NY-ESO-1b peptide vaccine contains the amino...
- NY-ESO-1-expressing artificial adjuvant vector cells ASP0739A preparation of artificial adjuvant vector cells (aAVCs) composed of modified human cells engineered to...
- NY-ESO-1/GLA-SE vaccine ID-G305A cancer vaccine composed of a recombinant form of the tumor antigen NY-ESO-1 and glucopyranosyl lipid...
- NY-ESO-1/LAGE-1 HLA class I/II peptide vaccineA cancer vaccine containing HLA class I- and II-binding peptides derived from the NY-ESO-1/LAGE-1...
- NY-ESO-1/MART-1 peptide-pulsed dendritic cell vaccineA cell-based cancer vaccine composed of dendritic cells (DC) pulsed with peptides derived from the...
- NY-ESO-1/PRAME/MAGE-A3/WT-1 peptide vaccineA peptide-based cancer vaccine comprised of synthetic peptides derived from the cancer-testis antigen...
- NY-ESO-1-specific CD4-positive T lymphocytesA preparation of autologous CD4+ T-lymphocytes sensitized to cancer-testis antigen NY-ESO-1, with potential...
- NY-ESO-1-specific TCR gene-transduced T lymphocytes TBI-1301Human peripheral blood T-lymphocytes transduced with a retroviral vector encoding a T-cell receptor (TCR)...
- NY-ESO-BA tumor-associated antigen belonging to the family of immunogenic testicular proteins that are aberrantly...
- nystatinThe active ingredient in a drug used to treat infections caused by fungi (a type of microorganism). Nystatin...
- NyvepriaA drug that is a form of filgrastim and is used to prevent infection in adults and children with neutropenia...
519 of 17,721 terms in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.